Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits

Saved in:
Bibliographic Details
Published inClinical oncology (Royal College of Radiologists (Great Britain)) Vol. 32; no. 10; p. e218
Main Authors Gatfield, E.R., Mukesh, M.B., Loo, S.W.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2020
The Royal College of Radiologists. Published by Elsevier Ltd
Subjects
Betacoronavirus - pathogenicity
Breast Neoplasms - drug therapy
Chemotherapy, Adjuvant - methods
Coronavirus Infections - drug therapy
COVID-19
Female
Humans
Letter
Pandemics
Pneumonia, Viral - drug therapy
Risk Assessment
SARS-CoV-2
Online AccessGet full text

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:0936-6555
1433-2981
1433-2981
DOI:10.1016/j.clon.2020.06.001